Predictive Oncology EPS - Earnings per Share 2010-2025 | POAI
Predictive Oncology eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Predictive Oncology Annual EPS | |
|---|---|
| 2024 | $-2.32 |
| 2023 | $-3.48 |
| 2022 | $-6.98 |
| 2021 | $-7.20 |
| 2020 | $-44.20 |
| 2019 | $-137.20 |
| 2018 | $-157.40 |
| 2017 | $-188.00 |
| 2016 | $-462.00 |
| 2015 | $-6,172.00 |
| 2014 | $-11,450.00 |
| 2013 | $-23,200.00 |
| 2012 | $-550.00 |
| 2011 | $-900.00 |
| 2010 | $-550.00 |
| 2009 | $-1,550.00 |
| Predictive Oncology Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.34 |
| 2024-12-31 | $-0.12 |
| 2024-09-30 | $-0.48 |
| 2024-06-30 | $-0.68 |
| 2024-03-31 | $-1.04 |
| 2023-12-31 | $-0.86 |
| 2023-09-30 | $-0.78 |
| 2023-06-30 | $-0.98 |
| 2023-03-31 | $-0.86 |
| 2022-12-31 | $-2.03 |
| 2022-09-30 | $-1.04 |
| 2022-06-30 | $-2.89 |
| 2022-03-31 | $-1.02 |
| 2021-12-31 | $-2.40 |
| 2021-09-30 | $-1.60 |
| 2021-06-30 | $-1.00 |
| 2021-03-31 | $-2.20 |
| 2020-12-31 | $-9.20 |
| 2020-09-30 | $-9.20 |
| 2020-06-30 | $-7.20 |
| 2020-03-31 | $-18.60 |
| 2019-12-31 | $-74.00 |
| 2019-09-30 | $-26.20 |
| 2019-06-30 | $4.80 |
| 2019-03-31 | $-41.80 |
| 2018-12-31 | $-49.60 |
| 2018-09-30 | $-37.80 |
| 2018-06-30 | $-40.00 |
| 2018-03-31 | $-30.00 |
| 2017-12-31 | $-32.00 |
| 2017-09-30 | $-32.00 |
| 2017-06-30 | $-82.00 |
| 2017-03-31 | $-42.00 |
| 2016-12-31 | $394.00 |
| 2016-09-30 | $-64.00 |
| 2016-06-30 | $-190.00 |
| 2016-03-31 | $-602.00 |
| 2015-12-31 | $-2,604.00 |
| 2015-09-30 | $-1,418.00 |
| 2015-06-30 | $-1,800.00 |
| 2015-03-31 | $-350.00 |
| 2014-12-31 | $-3,950.00 |
| 2014-09-30 | $-1,850.00 |
| 2014-06-30 | $-2,900.00 |
| 2014-03-31 | $-2,750.00 |
| 2013-12-31 | $-12,150.00 |
| 2013-09-30 | $-10,900.00 |
| 2013-06-30 | $-50.00 |
| 2013-03-31 | $-100.00 |
| 2012-12-31 | $-50.00 |
| 2012-09-30 | $-200.00 |
| 2012-06-30 | $-200.00 |
| 2012-03-31 | $-100.00 |
| 2011-12-31 | $-550.00 |
| 2011-09-30 | $-100.00 |
| 2011-06-30 | $-100.00 |
| 2011-03-31 | $-150.00 |
| 2010-12-31 | $-200.00 |
| 2010-09-30 | $-50.00 |
| 2010-06-30 | $0.00 |
| 2010-03-31 | $-300.00 |
| 2009-12-31 | $-150.00 |
| 2009-09-30 | $-400.00 |
| 2009-06-30 | $-400.00 |
| 2009-03-31 | $-600.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.084B | 57.36 |
| Doximity (DOCS) | United States | $11.307B | 52.35 |
| Hims & Hers Health (HIMS) | United States | $10.719B | 111.37 |
| Tempus AI (TEM) | United States | $9.847B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.340B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.717B | 0.00 |
| Privia Health (PRVA) | United States | $2.496B | 170.58 |
| Enovis (ENOV) | United States | $1.944B | 10.84 |
| Phreesia (PHR) | United States | $1.590B | 0.00 |
| 10x Genomics (TXG) | United States | $1.576B | 0.00 |
| Schrodinger (SDGR) | United States | $1.542B | 0.00 |
| Azenta (AZTA) | United States | $1.532B | 71.21 |
| Clover Health Investments (CLOV) | United States | $1.486B | 0.00 |
| Omnicell (OMCL) | United States | $1.344B | 23.71 |
| Evolent Health (EVH) | United States | $1.313B | 111.80 |
| Claritev (CTEV) | United States | $0.761B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.501B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.442B | 132.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.331B | 735.33 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.150B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.068B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |